Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

I bought Antares @ $3.95, I see a move to $4.35 short term

I bought Antares @ $3.95, I see a move to $4.35 short term

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Insmed: Top-Line Data Should Rally Stock | Investing.com

Insmed: Top-Line Data Should Rally Stock | Investing.com

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Biotechs In The Age Of Terror | Investing.com

Biotechs In The Age Of Terror | Investing.com

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks - Seeking Alpha

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks - Seeking Alpha

Weekend update with some charts, Market forecast and opinion. (VIDEO)

Weekend update with some charts, Market forecast and opinion. (VIDEO)

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential - Seeking Alpha

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential - Seeking Alpha

Market Commentary for This Week: Changing Course to Bullish - YouTube

Market Commentary for This Week: Changing Course to Bullish - YouTube

Market Forecast for the rest of this week ending 4/12/13 - YouTube

Market Forecast for the rest of this week ending 4/12/13 - YouTube

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha